Latest News and Press Releases

NEW YORK, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Renren Inc. (“Renren” or the “Company”) (NYSE: RENN). The investigation concerns...

NEW YORK, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS). Such investors are...

NEW YORK, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Faraday Future Intelligent Electric Inc. (“Faraday” or the “Company”) (NASDAQ: FFIE). Such...

NEW YORK, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Chegg, Inc. (“Chegg” or the “Company”) (NYSE: CHGG).   Such investors are advised to...

NEW YORK, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DocuSign, Inc. (“DocuSign” or the “Company”) (NASDAQ: DOCU).   Such investors are advised...

LOS ANGELES, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP and The Rosen Law Firm, P.A. announce that the United States District Court for the Central District of California has approved the...

NEW YORK, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Clarivate Plc (“Clarivate” or the “Company”) (NYSE: CLVT). Such investors are advised to...

NEW YORK, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of BridgeBio Pharma, Inc. (“BridgeBio” or the “Company”) (NASDAQ: BBIO). Such investors are...

NEW YORK, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Robinhood Markets, Inc. (“Robinhood” or the “Company”) (NASDAQ: HOOD).   Such investors...

NEW YORK, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Baidu, Inc. (“Baidu” or the “Company”) (NASDAQ: BIDU).   Such investors are advised to...